Just one US state legalizing cannabis can cost the pharmaceutical sector nearly $10 billion, according to a new, first-of-its-kind study from researchers at California Polytechnic State University and the University of New Mexico.
Researchers used survey data from more than 3,400 adult twins – 111 of which were identical – to study recent trends in cannabis use and the factors affecting it.
Further research into cannabis leaf extracts may one day lead to the discovery of new drugs for treating infertility, the researchers say.
Both the control group and the cannabis-consuming group had similar apathy scores.
The labs allegedly reported false information on their certificates of analysis.
Over 37,000 cannabis beverages have been recalled in Canada over fears that “pinhole leaks” could form in the aluminum cans, which could lead to leaks and a loss of carbonation.
Most American psychiatrists view psilocybin and ketamine as safer drugs than alprazolam (Xanax), methamphetamine, or alcohol, according to a new survey.
A psychedelic drug experience may alter people’s perspectives on death and dying in a similar way to those who have survived a near-death experience, a new study has found.
California’s cannabis regulator has seized over a billion dollars’ worth of illicit cannabis over the last thirteen months.